345 filings
Page 13 of 18
CORRESP
mr4uh9
27 Oct 16
Correspondence with SEC
12:00am
PRER14A
oxrf5fqxb4n styv
27 Oct 16
Preliminary revised proxy
12:00am
UPLOAD
d9bh1rla ycl3
25 Oct 16
Letter from SEC
12:00am
8-K
3c83d9xq263e ykbyk
24 Oct 16
Histogenics Corporation Provides NeocartĀ® Phase 3 Clinical Trial Enrollment Update
12:00am
D
6xofo qaaabsea
12 Oct 16
$30M in equity / options, sold $30M, 20 investors
12:00am
SC 13D/A
ll9obasug7 w8zs
6 Oct 16
Histogenics Corp
12:00am
S-3
lx3vyd
5 Oct 16
Shelf registration
12:00am
4
tcw 0vucdg5
3 Oct 16
HISTOGENICS / Michael Lewis ownership change
12:00am
PRE 14A
zz9h4y2nr42omtfagv
3 Oct 16
Preliminary proxy
12:00am
SC 13D/A
k12mb7mm241zevqt
3 Oct 16
Histogenics Corp
12:00am
4
ox9i51d6x4hfnd0nhy
3 Oct 16
Change in insider ownership
12:00am
4
vfg2a1u eg6e16
3 Oct 16
HISTOGENICS / KEVIN RAKIN ownership change
12:00am
4
ef4 hqpsu
3 Oct 16
Change in insider ownership
12:00am
8-K
gpr khyb2tbn
29 Sep 16
Histogenics Corporation Closes $30.0 Million Private Placement
12:00am
8-K
u5a3g
16 Sep 16
Histogenics Corporation Announces $30.0 Million Private Placement
12:00am
CT ORDER
61tce
15 Sep 16
Confidential treatment order
12:00am
8-K
0rz7g
11 Aug 16
Histogenics Corporation Announces Second Quarter 2016
12:00am
S-8
xsag7gi8s1muz48i1
30 Jun 16
Registration of securities for employees
12:00am
8-K
bk5qa4
22 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am